During the last session, Pfizer Inc. (NYSE:PFE)’s traded shares were 47.42 million, with the beta value of the company hitting 0.61. At the end of the trading day, the stock’s price was $25.26, reflecting an intraday loss of -3.84% or -$1.01. The 52-week high for the PFE share is $40.37, that puts it down -59.82 from that peak though still a striking 0.12% gain since the share price plummeted to a 52-week low of $25.23. The company’s market capitalization is $142.64B, and the average trade volume was 42.31 million shares over the past three months.
Pfizer Inc. (NYSE:PFE) trade information
Pfizer Inc. (PFE) registered a -3.84% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.84% in intraday trading to $25.26, hitting a weekly high. The stock’s 5-day price performance is -0.51%, and it has moved by -8.45% in 30 days. Based on these gigs, the overall price performance for the year is -35.77%.
Pfizer Inc. (PFE) estimates and forecasts
Statistics show that Pfizer Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Pfizer Inc. (PFE) shares have gone down -16.99% during the last six months, with a year-to-date growth rate more than the industry average at 21.20% against 3.90. In the rating firms’ projections, revenue will decrease -4.10% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 13.09B as predicted by 14 analyst(s). Meanwhile, a consensus of 13 analyst(s) estimates revenue growth to 12.28B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 16.59B and 12.73B respectively. In this case, analysts expect current quarter sales to shrink by -21.10% and then drop by -3.50% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -27.43%. While earnings are projected to return 20.03% in 2024, the next five years will return -1.33% per annum.
PFE Dividends
Pfizer Inc. is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Pfizer Inc. is 1.65, with the dividend yield indicating at 6.53 percent, continuing the trend of increasing dividends in recent years.
